These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 37503331)

  • 1. Integrating scRNA and bulk-RNA sequencing develops a cell senescence signature for analyzing tumor heterogeneity in clear cell renal cell carcinoma.
    Gong Q; Jiang Y; Xiong J; Liu F; Guan J
    Front Immunol; 2023; 14():1199002. PubMed ID: 37503331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comprehensive analysis of cellular senescence-related genes in the prognosis, tumor microenvironment, and immunotherapy/chemotherapy of clear cell renal cell carcinoma.
    Lu C; Wang Y; Nie L; Chen L; Li M; Qing H; Li S; Wu S; Wang Z
    Front Immunol; 2022; 13():934243. PubMed ID: 36189255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Unraveling the prognostic significance and molecular characteristics of tumor-infiltrating B lymphocytes in clear cell renal cell carcinoma through a comprehensive bioinformatics analysis.
    Yue Y; Cai X; Lu C; Sechi LA; Solla P; Li S
    Front Immunol; 2023; 14():1238312. PubMed ID: 37908350
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SPCS, a Novel Classifier System Based on Senescence Axis Regulators Reveals Tumor Microenvironment Heterogeneity and Guides Frontline Therapy for Clear Cell Renal Carcinoma.
    Jiang A; Liu Y; Zhu B; Fang Y; Qu L; Yang Q; Luo P; Cai C; Wang L
    Clin Genitourin Cancer; 2024 Apr; 22(2):497-513. PubMed ID: 38245436
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Senescence gene expression in clear cell renal cell carcinoma: Role of tumor immune microenvironment and senescence-associated survival prediction.
    Wu Y; Li X
    Medicine (Baltimore); 2023 Oct; 102(40):e35222. PubMed ID: 37800815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a metastasis-associated prognostic signature based on single-cell RNA-seq in clear cell renal cell carcinoma.
    Zhang C; He H; Hu X; Liu A; Huang D; Xu Y; Chen L; Xu D
    Aging (Albany NY); 2019 Nov; 11(22):10183-10202. PubMed ID: 31747386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating Bulk and Single-Cell RNA-Seq Data to Identify Prognostic Features Related to Activated Dendritic Cells in Clear-Cell Renal-Cell Carcinoma.
    Ye Z; Zhang Y; Xu J; Li K; Zhang J; Ivanova D; Zhang X; Liao S; Duan L; Li F; Chen X; Wang Y; Wang M; Xie B
    Int J Mol Sci; 2024 Aug; 25(17):. PubMed ID: 39273185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of a differentiation-related prognostic nomogram based on single-cell RNA sequencing in clear cell renal cell carcinoma.
    Xia ZN; Wu JG; Yao WH; Meng YY; Jian WG; Wang TD; Xue W; Yu YP; Cai LC; Wang XY; Zhang P; Li ZY; Zhou H; Jiang ZC; Zhou JY; Zhang C
    Sci Rep; 2022 Jun; 12(1):10973. PubMed ID: 35768519
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and Validation of Cytotoxicity-Related Features to Predict Prognostic and Immunotherapy Response in Patients with Clear Cell Renal Cell Carcinoma.
    Yu J; Zhao B; Yu Y
    Genet Res (Camb); 2024; 2024():3468209. PubMed ID: 39247556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrative Single-Cell Analysis Reveals Transcriptional and Epigenetic Regulatory Features of Clear Cell Renal Cell Carcinoma.
    Yu Z; Lv Y; Su C; Lu W; Zhang R; Li J; Guo B; Yan H; Liu D; Yang Z; Mi H; Mo L; Guo Y; Feng W; Xu H; Peng W; Cheng J; Nan A; Mo Z
    Cancer Res; 2023 Mar; 83(5):700-719. PubMed ID: 36607615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing.
    Weng KQ; Liu JY; Li H; She LL; Qiu JL; Qi H; Qi HY; Li YS; Dai YB
    Int Immunopharmacol; 2024 Mar; 130():111746. PubMed ID: 38442575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a Seven-Gene Signature Associated with CD8
    Chen Y; Zhou X; Xie Y; Wu J; Li T; Yu T; Pang Y; Du W
    Int J Mol Sci; 2023 Sep; 24(18):. PubMed ID: 37762031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and Validation of UPF1 as a Novel Prognostic Biomarker in Renal Clear Cell Carcinoma.
    Wu C; Li H; Chang W; Zhong L; Zhang L; Wen Z; Mai S
    Genes (Basel); 2022 Nov; 13(11):. PubMed ID: 36421841
    [No Abstract]   [Full Text] [Related]  

  • 15. Comprehensive analysis of necroptosis-related lncRNA signature with potential implications in tumor heterogeneity and prediction of prognosis in clear cell renal cell carcinoma.
    Lin H; Qu L; Chen G; Zhang C; Lu L; Chen Y
    Eur J Med Res; 2023 Jul; 28(1):236. PubMed ID: 37452355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Single-cell transcriptome analysis revealing the intratumoral heterogeneity of ccRCC and validation of MT2A in pathogenesis.
    Wang J; Zuo Z; Yu Z; Chen Z; Meng X; Ma Z; Niu J; Guo R; Tran LJ; Zhang J; Jiang T; Ye F; Ma B; Sun Z
    Funct Integr Genomics; 2023 Sep; 23(4):300. PubMed ID: 37713131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellular senescence and metabolic reprogramming model based on bulk/single-cell RNA sequencing reveals PTGER4 as a therapeutic target for ccRCC.
    Zhou L; Zeng Y; Liu Y; Du K; Luo Y; Dai Y; Pan W; Zhang L; Zhang L; Tian F; Gu C
    BMC Cancer; 2024 Apr; 24(1):451. PubMed ID: 38605343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal enhanced CT images reveal the tandem mechanism between tumor cells and immunocytes based on bulk/single-cell RNA sequencing.
    Liang H; Wu K; Wu R; Huang K; Deng Z; Chen H
    Funct Integr Genomics; 2023 Mar; 23(2):88. PubMed ID: 36933049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MDK promotes M2 macrophage polarization to remodel the tumour microenvironment in clear cell renal cell carcinoma.
    Shi N; Chen S; Wang D; Wu T; Zhang N; Chen M; Ding X
    Sci Rep; 2024 Aug; 14(1):18254. PubMed ID: 39107475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integrated analysis of single-cell and bulk transcriptome identifies a signature based on NK cell marker genes to predict prognosis and therapeutic response in clear cell renal cell carcinoma.
    Wang K; Yu M; Zhang Z; Yin R; Chen Q; Zhao X; Yu H
    Transl Cancer Res; 2023 May; 12(5):1270-1289. PubMed ID: 37304554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.